Privium Fund Management B.V. — 13F Holdings

2026 Q3  ·  70 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Privium Fund Management B.V. maintained a portfolio of 70 distinct positions. The most significant new addition was NEBIUS GROUP N.V., now representing 1.83% of the total fund value. They heavily accumulated shares in SPACE EXPLORATION TECHN CORP, increasing the position by 525.0%. Conversely, Privium Fund Management B.V. completely exited their position in AST SPACEMOBILE INC.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
70
Quarter
2026 Q3
Top Holding
TSLA (15.5%)
Top 10 Concentration
66.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 70

Privium Fund Management B.V. Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
TSLA
TESLA INC
Consumer Cyclical 15.49% 17.62% #1
Prev: #1
6.5
—
-3,000 -1.3%
P
S
225,000 $79,832,250 2022 Q2 13F Filing 2026-09-30 2026-11-03
SHOP
SHOPIFY INC
Technology 8.77% 7.76% #2
Prev: #2
5.5
—
-65,000 -17.6%
P
S
305,000 $45,231,500 2021 Q4 13F Filing 2026-09-30 2026-11-03
AMD
ADVANCED MICRO ...
Technology 7.36% 6.62% #3
Prev: #3
4.9
—
no change no change
P
S
62,000 $37,929,120 2022 Q3 13F Filing 2026-09-30 2026-11-03
SPCX
SPACE EXPLORATI...
ETF 7.32% 1.26% #4 18
Prev: #22
6.4
—
210,000 525.0%
P
S
250,000 $37,715,000 2026 Q2 13F Filing 2026-09-30 2026-11-03
PLTR
PALANTIR TECHNO...
Technology 7.26% 4.29% #5 2
Prev: #7
4.4
—
no change no change
P
S
200,000 $37,410,000 2021 Q4 13F Filing 2026-09-30 2026-11-03
AMZN
AMAZON COM INC
Consumer Cyclical 6.77% 6.13% #6 2
Prev: #4
3.7
—
no change no change
P
S
140,000 $34,881,000 2022 Q3 13F Filing 2026-09-30 2026-11-03
CBRS
CEREBRAS SYSTEM...
Technology 3.82% 2.46% #7 7
Prev: #14
4.5
—
50,500 83.5%
P
S
111,000 $19,719,150 2026 Q2 13F Filing 2026-09-30 2026-11-03
NVDA
NVIDIA CORPORAT...
Technology 3.59% 2.98% #8 3
Prev: #11
2.4
—
no change no change
P
S
81,000 $18,498,780 2022 Q2 13F Filing 2026-09-30 2026-11-03
SPOT
SPOTIFY TECHNOL...
Communication Services 3.12% 4.64% #9 3
Prev: #6
1.2
—
-22,000 -40.0%
P
S
33,000 $16,083,540 2021 Q4 13F Filing 2026-09-30 2026-11-03
IONS
IONIS PHARMACEU...
Healthcare 3.02% 4.66% #10 5
Prev: #5
3.2
—
29,079 9.1%
P
S
349,003 $15,582,984 2021 Q4 13F Filing 2026-09-30 2026-11-03
IREN
IREN LIMITED
Financial Services 2.94% 2.86% #11 1
Prev: #12
3.2
—
30,000 8.8%
P
S
370,150 $15,131,732 2025 Q3 13F Filing 2026-09-30 2026-11-03
ARWR
ARROWHEAD PHARM...
Healthcare 2.74% 3.51% #12 4
Prev: #8
1.6
—
-18,404 -7.9%
P
S
215,818 $14,125,288 2021 Q4 13F Filing 2026-09-30 2026-11-03
LMND
LEMONADE INC
Financial Services 2.37% 3.23% #13 3
Prev: #10
1.9
—
no change no change
P
S
270,259 $12,199,491 2025 Q3 13F Filing 2026-09-30 2026-11-03
OPEN
OPENDOOR TECHNO...
Real Estate 2.36% 3.35% #14 5
Prev: #9
3.4
—
1,200,000 30.4%
P
S
5,140,904 $12,183,942 2026 Q2 13F Filing 2026-09-30 2026-11-03
BIIB
BIOGEN INC
Healthcare 2.12% 1.92% #15 3
Prev: #18
1.8
—
no change no change
P
S
48,400 $10,932,592 2022 Q1 13F Filing 2026-09-30 2026-11-03
NBIS
NEBIUS GROUP N....
Communication Services 1.83% — #16
Prev: #—
4.2
—
40,000 —
NEW
40,000 $9,435,200 2026 Q3 13F Filing 2026-09-30 2026-11-03
PRQR
PROQR THRAPEUTI...
Healthcare 1.76% 1.89% #17 2
Prev: #19
1.2
—
-52,875 -1.0%
P
S
5,467,149 $9,075,467 2021 Q4 13F Filing 2026-09-30 2026-11-03
ARQT
ARCUTIS BIOTHER...
Healthcare 1.71% 1.92% #18 1
Prev: #17
1.2
—
-66,174 -16.6%
P
S
333,193 $8,806,291 2024 Q4 13F Filing 2026-09-30 2026-11-03
AXSM
AXSOME THERAPEU...
Healthcare 1.54% 1.80% #19 1
Prev: #20
2.6
—
3,000 7.5%
P
S
42,944 $7,918,444 2023 Q1 13F Filing 2026-09-30 2026-11-03
BBIO
BRIDGEBIO PHARM...
Healthcare 1.14% — #20
Prev: #—
4.0
—
89,151 —
NEW
89,151 $5,866,136 2026 Q3 13F Filing 2026-09-30 2026-11-03
QURE
UNIQURE NV
Healthcare 1.01% 2.78% #21 8
Prev: #13
0.4
—
-112,125 -34.2%
P
S
216,197 $5,223,319 2021 Q4 13F Filing 2026-09-30 2026-11-03
ALNY
ALNYLAM PHARMAC...
Healthcare 0.99% 0.63% #22 5
Prev: #27
3.4
—
9,235 81.2%
P
S
20,607 $5,084,571 2021 Q4 13F Filing 2026-09-30 2026-11-03
DNLI
DENALI THERAPEU...
Healthcare 0.92% 1.09% #23
Prev: #23
1.4
—
no change no change
P
S
229,857 $4,751,144 2026 Q1 13F Filing 2026-09-30 2026-11-03
BMRN
BIOMARIN PHARMA...
Healthcare 0.87% 0.79% #24 1
Prev: #25
1.3
—
no change no change
P
S
75,000 $4,500,000 2026 Q1 13F Filing 2026-09-30 2026-11-03
URGN
UROGEN PHARMA L...
Healthcare 0.85% 1.42% #25 4
Prev: #21
0.3
—
-102,085 -48.6%
P
S
107,915 $4,384,586 2024 Q4 13F Filing 2026-09-30 2026-11-03
NBIX
NEUROCRINE BIOS...
Healthcare 0.72% — #26
Prev: #—
3.8
—
26,200 —
NEW
26,200 $3,716,208 2021 Q4 13F Filing 2026-09-30 2026-11-03
RARE
ULTRAGENYX PHAR...
Healthcare 0.68% 2.08% #27 11
Prev: #16
0.3
—
-105,763 -31.2%
P
S
233,037 $3,502,546 2021 Q4 13F Filing 2026-09-30 2026-11-03
KRYS
KRYSTAL BIOTECH...
Healthcare 0.64% 0.76% #28 2
Prev: #26
0.8
—
-1,200 -10.7%
P
S
9,970 $3,315,623 2022 Q1 13F Filing 2026-09-30 2026-11-03
BNTX
BIONTECH SE
Healthcare 0.61% 0.51% #29
Prev: #29
2.2
—
2,000 6.6%
P
S
32,100 $3,155,430 2025 Q2 13F Filing 2026-09-30 2026-11-03
SRPT
SAREPTA THERAPE...
Healthcare 0.59% 0.45% #30 3
Prev: #33
2.7
—
30,105 22.1%
P
S
166,605 $3,035,543 2025 Q2 13F Filing 2026-09-30 2026-11-03
ABEV
AMBEV SA
Consumer Defensive 0.56% 0.46% #31 1
Prev: #32
2.7
—
187,556 23.4%
P
S
989,723 $2,889,991 2022 Q1 13F Filing 2026-09-30 2026-11-03
CRSP
CRISPR THERAPEU...
Healthcare 0.53% 0.45% #32 2
Prev: #34
2.2
—
4,000 8.9%
P
S
48,974 $2,709,242 2022 Q1 13F Filing 2026-09-30 2026-11-03
MGTX
MEIRAGTX HLDGS ...
Healthcare 0.44% 0.49% #33 2
Prev: #31
2.2
—
12,400 6.3%
P
S
208,512 $2,293,632 2024 Q1 13F Filing 2026-09-30 2026-11-03
BEAM
BEAM THERAPEUTI...
Healthcare 0.43% 0.44% #34 1
Prev: #35
2.7
—
21,000 29.9%
P
S
91,282 $2,231,845 2025 Q3 13F Filing 2026-09-30 2026-11-03
ZTS
ZOETIS INC
Healthcare 0.32% 0.23% #35 7
Prev: #42
2.6
—
6,321 36.5%
P
S
23,643 $1,650,991 2026 Q2 13F Filing 2026-09-30 2026-11-03
BTG
B2GOLD CORP
Basic Materials 0.27% 0.13% #36 12
Prev: #48
2.6
—
70,422 36.1%
P
S
265,505 $1,385,936 2021 Q4 13F Filing 2026-09-30 2026-11-03
FDMT
4D MOLECULAR TH...
Healthcare 0.25% 0.22% #37 6
Prev: #43
1.1
—
no change no change
P
S
90,110 $1,289,474 2023 Q3 13F Filing 2026-09-30 2026-11-03
TSHA
TAYSHA GENE THE...
Healthcare 0.22% 0.25% #38 3
Prev: #41
2.1
—
34,000 17.1%
P
S
232,900 $1,134,223 2024 Q2 13F Filing 2026-09-30 2026-11-03
RNAC
CARTESIAN THERA...
Healthcare 0.22% 0.29% #39 1
Prev: #38
0.6
—
3,325 2.2%
P
S
155,000 $1,117,550 2025 Q4 13F Filing 2026-09-30 2026-11-03
FATE
FATE THERAPEUTI...
Healthcare 0.19% 0.21% #40 4
Prev: #44
1.1
—
no change no change
P
S
414,311 $981,917 2024 Q3 13F Filing 2026-09-30 2026-11-03
AUTL
AUTOLUS THERAPE...
Healthcare 0.18% 0.11% #41 13
Prev: #54
2.6
—
106,060 29.2%
P
S
469,490 $910,811 2022 Q1 13F Filing 2026-09-30 2026-11-03
RIG
TRANSOCEAN LTD
Energy 0.16% 0.13% #42 9
Prev: #51
2.1
—
10,095 6.9%
P
S
155,699 $815,863 2025 Q3 13F Filing 2026-09-30 2026-11-03
MOH
MOLINA HEALTHCA...
Healthcare 0.15% 0.13% #43 9
Prev: #52
2.6
—
1,085 36.4%
P
S
4,064 $768,502 2026 Q1 13F Filing 2026-09-30 2026-11-03
LULU
LULULEMON ATHLE...
Consumer Cyclical 0.13% 0.11% #44 12
Prev: #56
2.6
—
1,960 38.7%
P
S
7,023 $675,542 2022 Q3 13F Filing 2026-09-30 2026-11-03
RCKT
ROCKET PHARMACE...
Healthcare 0.12% 0.15% #45 1
Prev: #46
1.0
—
no change no change
P
S
244,146 $642,104 2022 Q2 13F Filing 2026-09-30 2026-11-03
NOV
NOV INC
Energy 0.12% 0.14% #46 1
Prev: #47
0.5
—
-7,976 -19.0%
P
S
34,050 $637,757 2021 Q4 13F Filing 2026-09-30 2026-11-03
LXEO
LEXEO THERAPEUT...
Healthcare 0.10% 0.13% #47 3
Prev: #50
1.0
—
no change no change
P
S
155,000 $523,900 2024 Q4 13F Filing 2026-09-30 2026-11-03
SD
SANDRIDGE ENERG...
Energy 0.10% 0.10% #48 9
Prev: #57
1.0
—
no change no change
P
S
38,792 $523,304 2024 Q2 13F Filing 2026-09-30 2026-11-03
NU
NU HLDGS LTD
Financial Services 0.09% 0.11% #49 4
Prev: #53
0.5
—
-5,832 -13.3%
P
S
38,168 $483,207 2026 Q2 13F Filing 2026-09-30 2026-11-03
SA
SEABRIDGE GOLD ...
Basic Materials 0.08% 0.08% #50 8
Prev: #58
0.5
—
-2,340 -14.2%
P
S
14,172 $401,634 2022 Q3 13F Filing 2026-09-30 2026-11-03
Showing 1-50 of 70 holdings

Unlock Full Privium Fund Management B.V. Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →